Therapeutic potential of co-signaling receptor modulation in hepatitis B
Francesco Andreata(Vita-Salute San Raffaele University), Matteo Iannacone(Vita-Salute San Raffaele University)
Cited by 37
Related Papers
Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology
|Journal of Hepatology|2017|63
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination
|Nature Immunology|2024|55
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
|EMBO Molecular Medicine|2023|26